Browsing Tag
Cervical cancer
9 posts
Avacta (AIM: AVCT) opens AVA6103 Phase 1: Can sustained-release engineering salvage exatecan’s clinical legacy?
Avacta Therapeutics opens Phase 1 enrollment for AVA6103 exatecan PDC at two US oncology centers. Early data expected H2 2026. Read what it means for AVCT investors.
Seegene showcases HPV genotyping solution at EUROGIN 2025 amid stock surge
Discover how Seegene’s HPV genotyping solution unveiled at EUROGIN 2025 is advancing cervical cancer screening and impacting global diagnostics.
Understanding cervical cancer: Causes, symptoms, diagnosis, and prevention
Cervical cancer remains one of the most prevalent cancers affecting women worldwide, particularly those aged 45 to 65.…
Genmab, Pfizer’s tisotumab vedotin takes a leap towards EU approval for cervical cancer
In a significant development for cervical cancer treatment, Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have…
Model turned reality TV star Poonam Pandey passes away, leaving a legacy shrouded in mystery
In an announcement that has sent shockwaves across the entertainment landscape, Poonam Pandey, the model turned reality TV…
FDA approves Merck’s KEYTRUDA for advanced cervical cancer treatment
Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food…
Regeneron gets Libtayo approval in Japan for advanced cervical cancer
Regeneron Pharmaceuticals has secured the approval of the Japanese Ministry of Health, Labor and Welfare (MHLW) to manufacture…
Roche cobas HPV test for cervical screening gets FDA nod for use on cobas 6800/8800 Systems
Swiss healthcare company Roche has bagged approval from the US Food and Drug Administration to use its cobas…
FDA removes clinical hold on Advaxis’ Axalimogene Filolisbac, Durvalumab combo trial
Advaxis, a biotech firm based in New Jersey, announced a significant regulatory update as the U.S. Food and…